Diet drug Contrave kicks up a tempest amid uncertainty about heart attack and stroke effects

Researchers have a gentle warning for patients on the receiving end of 765,000 prescriptions for the weight-loss drug Contrave: The cardiovascular safety of this treatment "remains uncertain," they write in a newly published study. As for claims by the drug's maker that it dramatically drives down...
Source: Los Angeles Times - Science - Category: Science Authors: Source Type: news